Pancreatic Cancer Research at TGen Gets $18 Million Infusion
How bad is pancreatic cancer? Ninety percent of people who find out they have it die within a year. And the pancreas isn't even a brand-name digestive organ, like the kidney or liver.
The ghastly statistic is one reason the gene-science gurus at TGen in Phoenix are major recipients in $74 million of gifts being distributed nationwide by the Stand Up to Cancer foundation. TGen's getting $18 million.
What's great about this foundation is the aim to put research into practice -- and make patients well -- ASAP. The research conducted by TGen with its share of the gifts will be tried out at Scottsdale Healthcare at Shea hospital.
TGen says its role will be to:
...launch a series of innovative clinical trials in advanced pancreatic cancer. These clinical trials will be designed to deprive pancreatic tumors of crucial nutrients, thereby cutting off the fuel supply.
Sounds like a plan.
Get the This Week's Top Stories Newsletter
Every week we collect the latest news, music and arts stories — along with film and food reviews and the best things to do this week — so that you'll never miss Phoenix New Times' biggest stories.